India’s Hetero Labs Ltd said it received local regulatory approval to launch its version of anti-viral drug favipiravir for the treatment of COVID-19.
The drug, priced at 59 rupees (79 US cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.
Source:aljazeera.com
Protests over the war in Gaza have taken hold at a handful of elite US universities as officials scramble to defuse demonstrations. Police moved to
The Israeli military’s intelligence chief has resigned, saying he took responsibility for the failures before Hamas’s attack on Israel on 7 October. The Israel Defense
A Russian missile attack has killed 14 people in the city of Chernihiv in northern Ukraine, according to Ukrainian officials. Ukraine’s interior minister said there
The United Nations has called on Iran and Israel to show restraint, with the threat of a full-scale direct conflict between the two countries looming
2021 © Kencity Media Limited | Powered by Maxme Group
